Loomis, Sayles & Company’s PTC Therapeutics PTCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,061,398
| Closed | -$43.2M | – | 1001 |
|
|
2023
Q2 | $43.2M | Sell |
1,061,398
-169,684
| -14% | -$6.9M | 0.07% | 129 |
|
|
2023
Q1 | $59.6M | Buy |
1,231,082
+4,817
| +0.4% | +$233K | 0.1% | 99 |
|
|
2022
Q4 | $46.8M | Sell |
1,226,265
-392,629
| -24% | -$15M | 0.09% | 119 |
|
|
2022
Q3 | $81.3M | Sell |
1,618,894
-17,941
| -1% | -$901K | 0.16% | 74 |
|
|
2022
Q2 | $65.6M | Sell |
1,636,835
-9,949
| -0.6% | -$399K | 0.12% | 82 |
|
|
2022
Q1 | $61.4M | Buy |
1,646,784
+110,561
| +7% | +$4.12M | 0.08% | 103 |
|
|
2021
Q4 | $61.2M | Buy |
1,536,223
+247,968
| +19% | +$9.88M | 0.07% | 119 |
|
|
2021
Q3 | $47.9M | Buy |
1,288,255
+383,338
| +42% | +$14.3M | 0.06% | 156 |
|
|
2021
Q2 | $38.3M | Buy |
904,917
+1,951
| +0.2% | +$82.5K | 0.05% | 213 |
|
|
2021
Q1 | $42.8M | Buy |
902,966
+37,506
| +4% | +$1.78M | 0.06% | 175 |
|
|
2020
Q4 | $52.8M | Buy |
865,460
+67,643
| +8% | +$4.13M | 0.07% | 126 |
|
|
2020
Q3 | $37.3M | Buy |
797,817
+131,287
| +20% | +$6.14M | 0.05% | 138 |
|
|
2020
Q2 | $33.8M | Buy |
666,530
+227,379
| +52% | +$11.5M | 0.05% | 141 |
|
|
2020
Q1 | $19.6M | Buy |
439,151
+2,666
| +0.6% | +$119K | 0.04% | 168 |
|
|
2019
Q4 | $21M | Buy |
436,485
+49,258
| +13% | +$2.37M | 0.04% | 204 |
|
|
2019
Q3 | $13.1M | Buy |
+387,227
| New | +$13.1M | 0.03% | 289 |
|
|
2015
Q1 | – | Sell |
-263,918
| Closed | -$13.7M | – | 757 |
|
|
2014
Q4 | $13.7M | Buy |
263,918
+31,312
| +13% | +$1.62M | 0.04% | 453 |
|
|
2014
Q3 | $10.2M | Buy |
+232,606
| New | +$10.2M | 0.03% | 483 |
|
|
2014
Q2 | – | Sell |
-473,215
| Closed | -$12.4M | – | 766 |
|
|
2014
Q1 | $12.4M | Buy |
+473,215
| New | +$12.4M | 0.04% | 461 |
|